Displaying all 2 publications

Abstract:
Sort:
  1. Fulltext Industrial design modeling for a glucose sensor device
    Soo Li Choong, Khairul Nazri Abd Wahib, Sheridan Saidin, Mohd Rohaizam Mohd Tahar
    Malaysian Journal of Public Health Medicine, 2016;16(101):43-47.
    MyJurnal
    This paper presents the methodologies and the systematic approaches in the industrial design development process
    to incorporate aesthetic and affective elements in a Glucose Sensor device. EQUID (Ergonomics Quality in Design)
    design approach was applied where users’ requirements were identified in early design stage utilizing Kawakita Jiro
    (KJ) method. Benchmarking and trend analysis were also conducted in early stage to understand market trends,
    compare features and faults in existing product in the market, at the same time finding opportunities for
    improvement in our own product. The development of the shape of the Glucose Sensor device, the color chosen and
    the branding profile creation were also discussed in the paper. Several design concepts and prototypes have been
    developed and user’s emotions towards each concept in focus group have been captured. The survey was carried out
    at the end of this paper to assess the design effectiveness.
  2. Fulltext Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)
    Sarin SK, Choudhury A, Lau GK, Zheng MH, Ji D, Abd-Elsalam S, et al.
    Hepatol Int, 2020 Sep;14(5):690-700.
    PMID: 32623632 DOI: 10.1007/s12072-020-10072-8
    BACKGROUND AND AIMS: COVID-19 is a dominant pulmonary disease, with multisystem involvement, depending upon comorbidities. Its profile in patients with pre-existing chronic liver disease (CLD) is largely unknown. We studied the liver injury patterns of SARS-Cov-2 in CLD patients, with or without cirrhosis.

    METHODS: Data was collected from 13 Asian countries on patients with CLD, known or newly diagnosed, with confirmed COVID-19.

    RESULTS: Altogether, 228 patients [185 CLD without cirrhosis and 43 with cirrhosis] were enrolled, with comorbidities in nearly 80%. Metabolism associated fatty liver disease (113, 61%) and viral etiology (26, 60%) were common. In CLD without cirrhosis, diabetes [57.7% vs 39.7%, OR = 2.1 (1.1-3.7), p = 0.01] and in cirrhotics, obesity, [64.3% vs. 17.2%, OR = 8.1 (1.9-38.8), p = 0.002] predisposed more to liver injury than those without these. Forty three percent of CLD without cirrhosis presented as acute liver injury and 20% cirrhotics presented with either acute-on-chronic liver failure [5 (11.6%)] or acute decompensation [4 (9%)]. Liver related complications increased (p 

Related Terms
    Try searching for something
Filters
Contact Us

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links